Walleye Capital
PCRX icon

Walleye Capital’s Pacira BioSciences PCRX Stock Holding History

Walleye Capital’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-119,857
Closed -$2.98M – 4914
2025
Q1 		$2.98M Buy
119,857
+72,014
+151% +$1.72M 0.01% 1144
2024
Q4 		$901K Buy
+47,843
New +$840K ﹤0.01% 2473
2024
Q2 		– Sell
-2,179
Closed -$63.7K – 5897
2024
Q1 		$63.7K Sell
2,179
-6,404
-75% -$197K ﹤0.01% 4591
2023
Q4 		$290K Buy
+8,583
New +$251K ﹤0.01% 3395
2023
Q1 		– Sell
-109,171
Closed -$4.22M – 4263
2022
Q4 		$4.22M Buy
109,171
+1,334
+1% +$64.9K 0.08% 307
2022
Q3 		$5.74M Buy
107,837
+69,678
+183% +$3.87M 0.11% 203
2022
Q2 		$2.23M Sell
38,159
-96,868
-72% -$6.35M 0.06% 330
2022
Q1 		$10.3M Buy
135,027
+19,930
+17% +$1.33M 0.28% 70
2021
Q4 		$6.92M Buy
115,097
+24,315
+27% +$1.34M 0.22% 96
2021
Q3 		$5.08K Sell
90,782
-3,636
-4% -$210K 0.14% 88
2021
Q2 		$5.73K Buy
94,418
+54,056
+134% +$3.42M 0.2% 73
2021
Q1 		$2.83K Sell
40,362
-4,380
-10% -$313K 0.16% 100
2020
Q4 		$2.68K Buy
+44,742
New +$2.62M 0.18% 91
2020
Q2 		– Sell
-5,280
Closed -$177K – 879
2020
Q1 		$177K Buy
5,280
+5,080
+2,540% +$211K 0.04% 471
2019
Q4 		$9K Buy
+200
New +$8.49K ﹤0.01% 1658
2019
Q3 		– Sell
-2,576
Closed -$112K – 2170
2019
Q2 		$112K Buy
+2,576
New +$109K 0.01% 1182

Other funds holding PCRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $372M AUM 14.96% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Walleye Capital's PCRX Position: Q2 2025 in Review

Walleye Capital sold out of Pacira BioSciences (PCRX) in Q2 2025, closing a stake of 119,857 shares — an estimated $2.98M sold.

Walleye Capital first reported a position in PCRX in Q2 2019 and held it in 16 quarters. The position peaked at $10.3M in Q1 2022. 233 funds tracked by Wall St. Rank hold PCRX as of Q2 2025.

  • Walleye Capital reported no remaining Pacira BioSciences position as of Q2 2025 after selling out during the quarter.
  • Walleye Capital sold 119,857 Pacira BioSciences shares in Q2 2025, an estimated $2.98M.
  • Walleye Capital first reported a position in Pacira BioSciences in Q2 2019 and held it in 16 quarters.
  • Walleye Capital's Pacira BioSciences position peaked at $10.3M in Q1 2022.
  • 233 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2025.

Based on Walleye Capital's 13F filing for Q2 2025, filed 13 Aug 2025.